Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Treace Medical Concepts Inc
(NQ:
TMCI
)
6.420
+0.220 (+3.55%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Treace Medical Concepts Inc
< Previous
1
2
3
4
5
Next >
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance
February 27, 2024
From
Treace Medical Concepts, Inc.
Via
GlobeNewswire
Earnings Scheduled For February 27, 2024
February 27, 2024
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.
Via
Benzinga
Earnings Preview For Treace Medical Concepts
February 26, 2024
Via
Benzinga
Treace to Report Fourth Quarter and Full-Year 2023 Financial Results
February 07, 2024
Company to Host Conference Call on Tuesday, February 27, 2024 at 4:30 pm ET
From
Treace Medical Concepts, Inc.
Via
GlobeNewswire
6 Analysts Assess Treace Medical Concepts: What You Need To Know
December 22, 2023
Via
Benzinga
Analyst Ratings for Treace Medical Concepts
November 10, 2023
Via
Benzinga
The Latest Analyst Ratings for Treace Medical Concepts
September 29, 2023
Via
Benzinga
Treace Announces Interim 3-Year ALIGN3D™ Clinical Study Data at the 2024 ACFAS Scientific Conference Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure
February 02, 2024
From
Treace Medical Concepts, Inc.
Via
GlobeNewswire
Treace to Highlight Latest Product Innovations and ALIGN3D™ Study Outcomes at the 2024 ACFAS Annual Scientific Conference
February 01, 2024
Company Previews New SpeedPlate™ Configurations, Announces Full Commercial Release of its Micro-Lapiplasty™ System and Limited Clinical Release of its Mini-Adductoplasty™ System and RedPoint™...
From
Treace Medical Concepts, Inc.
Via
GlobeNewswire
Analyst Ratings for Treace Medical Concepts
August 28, 2023
Via
Benzinga
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2023 Revenue
January 08, 2024
Company to Present at J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024 at 3:45 pm Pacific Time
From
Treace Medical Concepts, Inc.
Via
GlobeNewswire
Treace to Present at 42nd Annual J.P. Morgan Healthcare Conference
December 19, 2023
Tuesday, January 9, 2024, at 3:45 pm Pacific Time
From
Treace Medical Concepts, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
November 10, 2023
Via
Benzinga
Why Wynn Resorts Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
November 10, 2023
Shares of Wynn Resorts, Limited (NASDAQ: WYNN) fell sharply on Friday after the company reported third-quarter financial results.
Via
Benzinga
Dow Gains Over 100 Points; Wynn Resorts Earnings Top Views
November 10, 2023
U.S. stocks traded higher this morning, with the Dow Jones gaining over 100 points on Friday. Following the market opening Friday, the Dow traded up 0.37% to 34,016.77 while the NASDAQ rose 0.74% to...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Treace Medical Concepts Disappoints On Q3 Results, Lowers FY23 Guidance
November 09, 2023
Treace Medical Concepts Inc (NASDAQ: TMCI) shares are trading lower after the company reported worse-than-expected third-quarter financial results and lowered full-year 2023 revenue
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
November 09, 2023
Via
Benzinga
Treace Medical Concepts Reports Third Quarter 2023 Financial Results
November 09, 2023
From
Treace Medical Concepts, Inc.
Via
GlobeNewswire
Treace to Present at Stifel 2023 Healthcare Conference
October 30, 2023
From
Treace Medical Concepts, Inc.
Via
GlobeNewswire
Earnings Scheduled For November 9, 2023
November 09, 2023
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million.
Via
Benzinga
Treace to Report Third Quarter 2023 Financial Results
October 16, 2023
Company to Host Conference Call on Thursday, November 9, 2023 at 4:30 pm ET
From
Treace Medical Concepts, Inc.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Thursday
October 05, 2023
On Thursday, 369 companies hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
September 26, 2023
On Tuesday, 386 stocks made new 52-week lows.
Via
Benzinga
Treace Highlights New Product Innovations and Updated ALIGN3D™ Clinical Study Data at the American Orthopaedic Foot & Ankle Society Annual Meeting 2023
September 20, 2023
From
Treace Medical Concepts, Inc.
Via
GlobeNewswire
Treace Medical Concepts Announces New Patent Covering Instrumented Bunion Correction Procedures and Milestone 50th U.S. Patent
September 14, 2023
From
Treace Medical Concepts, Inc.
Via
GlobeNewswire
Treace Medical Concepts Announces Limited Market Release of New Complementary Technologies for Treating Bunions and Related Procedures
September 11, 2023
From
Treace Medical Concepts, Inc.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Friday
September 08, 2023
Friday's session saw 225 companies set new 52-week lows.
Via
Benzinga
Treace Announces Participation in the 21st Annual Morgan Stanley Global Healthcare Conference
August 22, 2023
From
Treace Medical Concepts, Inc.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Thursday
September 07, 2023
On Thursday, 283 companies set new 52-week lows.
Via
Benzinga
Treace Medical Concepts Appoints Nathan Minnich as Senior Vice President, Marketing
August 21, 2023
From
Treace Medical Concepts, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.